Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Nuno Palma

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Proteins|June 5, 2003
Modeling protein complexes with BiGGERLudwig Krippahl, José J Moura, P Nuno Palma
CNS Drug Reviews|September 27, 2007
Catechol-O-methyltransferase and its inhibitors in Parkinson's diseaseMaria João Bonifácio, P Nuno Palma, Luís Almeida, et al.
Journal of Computational Chemistry|January 27, 2012
Computation of the binding affinities of catechol-O-methyltransferase inhibitors: multisubstate relative free energy calculationsP Nuno Palma, Maria João Bonifácio, Ana Isabel Loureiro, et al.
FEBS Letters|August 10, 2005
Synechocystis ferredoxin/ferredoxin-NADP(+)-reductase/NADP+ complex: Structural model obtained by NMR-restrained dockingP Nuno Palma, Bernard Lagoutte, Ludwig Krippahl, et al.
Journal of Medicinal Chemistry|November 30, 2004
Synthesis, biological evaluation, and molecular modeling studies of a novel, peripherally selective inhibitor of catechol-O-methyltransferaseDavid A Learmonth, P Nuno Palma, Maria A Vieira-Coelho, et al.
Chembiochem : a European Journal of Chemical Biology|July 17, 2022
Inactivation Mechanism of the Fatty Acid Amide Hydrolase Inhibitor BIA 10-2474Nuno M F S A Cerqueira, Marco Neves, Juliana Rocha, et al.
Journal of Medicinal Chemistry|March 26, 2010
Discovery of a long-acting, peripherally selective inhibitor of catechol-O-methyltransferaseLászló E Kiss, Humberto S Ferreira, Leonel Torrão, et al.
British Journal of Clinical Pharmacology|January 23, 2013
Opicapone: a short lived and very long acting novel catechol-O-methyltransferase inhibitor following multiple dose administration in healthy subjectsJosé Francisco Rocha, Luis Almeida, Amílcar Falcão, et al.
Clinical Pharmacokinetics|December 19, 2012
Pharmacokinetics, pharmacodynamics and tolerability of opicapone, a novel catechol-O-methyltransferase inhibitor, in healthy subjects: prediction of slow enzyme-inhibitor complex dissociation of a short-living and very long-acting inhibitorLuis Almeida, José Francisco Rocha, Amílcar Falcão, et al.
Chemmedchem|August 17, 2018
Discovery of a Potent, Long-Acting, and CNS-Active Inhibitor (BIA 10-2474) of Fatty Acid Amide HydrolaseLászló E Kiss, Alexandre Beliaev, Humberto S Ferreira, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Proteins|June 5, 2003
Modeling protein complexes with BiGGERLudwig Krippahl, José J Moura, P Nuno Palma
CNS Drug Reviews|September 27, 2007
Catechol-O-methyltransferase and its inhibitors in Parkinson's diseaseMaria João Bonifácio, P Nuno Palma, Luís Almeida, et al.
Journal of Computational Chemistry|January 27, 2012
Computation of the binding affinities of catechol-O-methyltransferase inhibitors: multisubstate relative free energy calculationsP Nuno Palma, Maria João Bonifácio, Ana Isabel Loureiro, et al.
FEBS Letters|August 10, 2005
Synechocystis ferredoxin/ferredoxin-NADP(+)-reductase/NADP+ complex: Structural model obtained by NMR-restrained dockingP Nuno Palma, Bernard Lagoutte, Ludwig Krippahl, et al.
Journal of Medicinal Chemistry|November 30, 2004
Synthesis, biological evaluation, and molecular modeling studies of a novel, peripherally selective inhibitor of catechol-O-methyltransferaseDavid A Learmonth, P Nuno Palma, Maria A Vieira-Coelho, et al.
Chembiochem : a European Journal of Chemical Biology|July 17, 2022
Inactivation Mechanism of the Fatty Acid Amide Hydrolase Inhibitor BIA 10-2474Nuno M F S A Cerqueira, Marco Neves, Juliana Rocha, et al.
Journal of Medicinal Chemistry|March 26, 2010
Discovery of a long-acting, peripherally selective inhibitor of catechol-O-methyltransferaseLászló E Kiss, Humberto S Ferreira, Leonel Torrão, et al.
British Journal of Clinical Pharmacology|January 23, 2013
Opicapone: a short lived and very long acting novel catechol-O-methyltransferase inhibitor following multiple dose administration in healthy subjectsJosé Francisco Rocha, Luis Almeida, Amílcar Falcão, et al.
Clinical Pharmacokinetics|December 19, 2012
Pharmacokinetics, pharmacodynamics and tolerability of opicapone, a novel catechol-O-methyltransferase inhibitor, in healthy subjects: prediction of slow enzyme-inhibitor complex dissociation of a short-living and very long-acting inhibitorLuis Almeida, José Francisco Rocha, Amílcar Falcão, et al.
Chemmedchem|August 17, 2018
Discovery of a Potent, Long-Acting, and CNS-Active Inhibitor (BIA 10-2474) of Fatty Acid Amide HydrolaseLászló E Kiss, Alexandre Beliaev, Humberto S Ferreira, et al.
Pageof 1